Adherence to and satisfaction with oral outpatient thromboembolism prophylaxis compared to parenteral: SALTO study

Geerts, 2004, Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy, Chest, 126, 338S, 10.1378/chest.126.3_suppl.338S Barba Martín, 2005 2003, Guía clínica: profilaxis de la enfermedad tromboembólica venosa en la cirugía ortopédica y traumatología, Soc Esp Cirug Ortopéd Traumatol Cohen, 2007, Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality, Thromb Haemost, 98, 756, 10.1160/TH07-03-0212 Freedman, 2000, A meta analysis of thromboembolic prophylaxis following elective total hip arthroplasty, J Bone Joint Surg Am, 82-A, 929, 10.2106/00004623-200007000-00004 2006, Monográfico II. Forum multidisciplinar de la enfermedad tromboembólica venosa, Soc Esp Med Int Spahn, 2002, Compliance with self-administration of heparin injections in outpatients, Eur J Trauma Emerg Surg, 104, 10.1007/s00068-002-1176-1 Eriksson, 2008, Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty, N Engl J Med, 358, 2765, 10.1056/NEJMoa0800374 Lassen, 2008, Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty, N Engl J Med, 358, 2776, 10.1056/NEJMoa076016 Kakkar, 2008, Rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind randomised controlled trial, Lancet, 372, 31, 10.1016/S0140-6736(08)60880-6 Nieto, 2012, Dabigatran, rivaroxaban and apixaban versus enoxaparin for thomboprophylaxis after total knee or hip arthroplasty: pool-analysis of phase III randomized clinical trials, Thromb Res, 130, 183, 10.1016/j.thromres.2012.02.011 Imberti, 2012, Therapeutic potential of apixaban in the prevention of venous thromboembolism in patients undergoing total knee replacement surgery, J Thromb Thrombolysis, 10.1007/s11239-012-0716-8 Morisky, 1986, Concurrent and predictive validity of a self-reported measure of medication adherence, Med Care, 24, 67, 10.1097/00005650-198601000-00007 Atkinson, 2004, Validation of a general measure of treatment satisfaction: the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease, Health Qual Life Outcomes, 2, 12, 10.1186/1477-7525-2-12 Anderson, 2004, Development and validation of the Insulin Treatment Satisfaction Questionnaire, Clin Ther, 26, 565, 10.1016/S0149-2918(04)90059-8 Carrasco Carrasco, 2010, Prevención de la enfermedad tromboembólica venosa en pacientes ambulatorios con patología médica, Semergen, 36, 150, 10.1016/j.semerg.2009.12.010 Granero, 2007 Krueger, 2005, Medication adherence and persistence: a comprehensive review, Adv Ther, 22, 313, 10.1007/BF02850081 Warwick, 2007, Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared to the time course of thromboembolic events, J Bone Joint Surg Br, 89, 799, 10.1302/0301-620X.89B6.18844